European defense stocks fell to their lowest levels since early September on Friday, following comments from Ukrainian President Volodymyr Zelensky expressing willingness for “honest” work on a U.S.-backed plan to end the war.

Shares in Roche Holding (ROG.S) rose about 2% on Monday, outperforming a largely unchanged European healthcare index, after the Swiss drugmaker announced it is advancing its experimental obesity drug, CT-388, to a late-stage clinical trial.

European stocks fell on Tuesday, led by losses in France amid growing expectations that the country’s minority government could be toppled next month.

European defense company shares plummeted on Monday, erasing some of their year-to-date gains, as a sharp selloff in equities, triggered by U.S. President Donald Trump’s sweeping tariffs, intensified.

European shares hit record levels on Monday, led by a strong performance in defence stocks, as political leaders in the region called for an emergency summit on the Ukraine war.

European shares were on course to post their worst week in three months on Friday, as U.S. President-elect Donald Trump's comments about potential tariffs on the European Union spooked investors already worried about the U.S. rate outlook, News.az reports citing Investing.